
Replimune Group, Inc. is a biotechnology company headquartered in Woburn, MA, founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies.
Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. The Director of HCP Marketing will play a leading role in developing the commercial efforts for Replimune's first product, RP1. This role is responsible for creating and executing the vision, strategic, and tactical marketing plans for RP1 in PD-1 failed Melanoma.
Replimune Group, Inc. is a biotechnology company headquartered in Woburn, MA, founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies.